BIOMAT Database Logo BIOMAT Database Logo

[Mechanism of action of new sympathomimetics (dopamine and wyamine) and the ir therapeutic possibilities in cardiogenic shock]. 1971

D Döring

UI MeSH Term Description Entries
D008616 Mephentermine A sympathomimetic agent with specificity for alpha-1 adrenergic receptors. It is used to maintain BLOOD PRESSURE in hypotensive states such as following SPINAL ANESTHESIA. Mephentermine Sulfate,Mephentermine Sulfate (2:1),Sulfate, Mephentermine
D001775 Blood Circulation The movement of the BLOOD as it is pumped through the CARDIOVASCULAR SYSTEM. Blood Flow,Circulation, Blood,Blood Flows,Flow, Blood
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012770 Shock, Cardiogenic Shock resulting from diminution of cardiac output in heart disease. Cardiogenic Shock
D013566 Sympathomimetics Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. Amines, Sympathomimetic,Sympathomimetic,Sympathomimetic Agent,Sympathomimetic Drug,Sympathomimetic Agents,Sympathomimetic Drugs,Sympathomimetic Effect,Sympathomimetic Effects,Agent, Sympathomimetic,Agents, Sympathomimetic,Drug, Sympathomimetic,Drugs, Sympathomimetic,Effect, Sympathomimetic,Effects, Sympathomimetic,Sympathomimetic Amines

Related Publications

D Döring
[Cardiogenic shock-- new therapeutic strategies].
May 2005, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
D Döring
[Dopamine and cardiogenic shock].
May 1969, La Clinica terapeutica,
D Döring
[Dopamine in cardiogenic shock].
September 1976, Medizinische Klinik,
D Döring
[Dopamine in cardiogenic shock].
October 1979, Deutsche medizinische Wochenschrift (1946),
D Döring
Vasodilator action of a "pressor amine," mephentermine (Wyamine), in circulatory shock.
December 1965, The American journal of cardiology,
D Döring
Dopamine for cardiogenic shock.
December 1973, JAMA,
D Döring
[Dopamine treatment in cardiogenic shock].
June 1985, Ugeskrift for laeger,
D Döring
Mechanism of action of dopamine in endotoxin shock.
January 1970, The Journal of the Oklahoma State Medical Association,
D Döring
[Possibilities of assisted circulation in cardiogenic shock].
January 1971, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
D Döring
[Ivabradine - a new therapeutic option for cardiogenic shock?].
May 2009, Herz,
Copied contents to your clipboard!